Traduction de «Fire inspection testing technology expert » (Anglais → Français) :

Decision 2010/461/CFSP funded the Expert Meeting on Multi-spectral Imaging and Infrared for Ón-Site Inspections (MSEM-11) held between 30 March and 1 April 2011 in Rome, Italy, which concluded that Commercial Off-The-Shelf (COTS) instruments should be considered for OSI use since they represent the most cost-effective option for this technology.

76. Draws attention to the fact that the current 20 % target is based on the contribution made by nuclear power to the energy mix in number of Member States; notes that the IEA's World Energy Outlook 2011 includes a ‘lower-nuclear’ case according to which the projected increase in worldwide CO2 emissions from the power sector would be substantially higher in the medium term due to an increased use of fossil fuels; reiterates that the decision by some Member States to shut down some existing nuclear reactors must not serve to justify reducing the level of ambition of their current climate policies; points out that, according to the IEA, achieving the 2°C goal would require faster development and deployment of CCS technologies in both coal ...[+++]- and gas-fired power plants; notes, however, that CCS technology is still at the testing and pre-commercial stage, so alternative scenarios also need to be considered, such as high renewables and energy efficiency scenarios; thus calls for increased support for the development and application of breakthrough technologies in order to increase energy efficiency and decouple economic growth from energy consumption;

In accordance with the procedures referred to in the first subparagraph of paragraph 1, phytosanitary measures adopted by a third country for export into the Community shall be recognised as equivalent to the phytosanitary measures laid down in this Directive, in particular to those specified in Annex IV, if that third country objectively demonstrates to the Community that its measures achieve the Community's appropriate level of phytosanitary protection and if this is confirmed by the conclusions resulting from findings made on the occasion of reasonable access of the experts ...[+++] referred to in Article 21 for inspection, testing and other relevant procedures in the relevant third country.

(b) in paragraph 5, in the second subparagraph, the following sentence shall be added after the third sentence:"This provision shall not apply to expenses resulting from the following types of requests made on the occasion of the participation of the said experts in the Member States' import inspections: laboratory testing and sampling for visual inspection or for laboratory testing, and already covered by the fees referred to in Article 13d".

11. Notes that genetic testing, analyses and diagnosis are medical procedures that must invariably conform to the rules of what is termed 'good clinical practice', and that high standards of genetic testing are essential, given that decisions having a crucial bearing on a person's life are taken in the light of the results; genetic testing must enable individuals to take independent decisions and make choices with full knowledge of the facts, where treatments and other factors which may determine a person's quality of life are concer ...[+++]ned; however, if the advantages of genetic testing are to be realised, the forms of testing offered (tests must be accurate, and equal access to testing services afforded to all), the context (expert counselling services which do not encroach on personal self-determination), and technology may become equally important factors;

In order to ensure a high level of protection and coherence, protective measures should be based on risk assessment, taking into account all relevant risk factors, including technological aspects, the best available scientific evidence and the availability of inspection sampling and testing methods.